Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment.

Man Fung YuenDanny Ka-Ho WongThomas SchluepChing-Lung LaiCarlo FerrariStephen LocarniniRegina Cheuk-Lam LoRobert G GishJames HamiltonChristine I WooddellLoey Lung-Yi MakBruce D Given

Published in: Gut (2021)

NCT02065336.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
hepatitis b virus
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported
liver fibrosis
nucleic acid